Wells Fargo’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-25,093
| Closed | -$461K | – | 7315 |
|
|
2020
Q4 | $461K | Buy |
25,093
+12,113
| +93% | +$223K | ﹤0.01% | 4489 |
|
|
2020
Q3 | $239K | Sell |
12,980
-2,180
| -14% | -$40.1K | ﹤0.01% | 4712 |
|
|
2020
Q2 | $227K | Buy |
15,160
+6,017
| +66% | +$90.1K | ﹤0.01% | 4673 |
|
|
2020
Q1 | $145K | Sell |
9,143
-551
| -6% | -$8.74K | ﹤0.01% | 4694 |
|
|
2019
Q4 | $157K | Sell |
9,694
-86
| -0.9% | -$1.39K | ﹤0.01% | 4915 |
|
|
2019
Q3 | $145K | Buy |
9,780
+159
| +2% | +$2.36K | ﹤0.01% | 4934 |
|
|
2019
Q2 | $159K | Sell |
9,621
-830
| -8% | -$13.7K | ﹤0.01% | 4896 |
|
|
2019
Q1 | $181K | Buy |
10,451
+4,789
| +85% | +$82.9K | ﹤0.01% | 4803 |
|
|
2018
Q4 | $100K | Sell |
5,662
-12,284
| -68% | -$217K | ﹤0.01% | 5041 |
|
|
2018
Q3 | $326K | Buy |
17,946
+4,114
| +30% | +$74.7K | ﹤0.01% | 4587 |
|
|
2018
Q2 | $271K | Buy |
+13,832
| New | +$271K | ﹤0.01% | 4717 |
|
|
2017
Q4 | – | Sell |
-3,610
| Closed | -$38K | – | 6070 |
|
|
2017
Q3 | $38K | Buy |
+3,610
| New | +$38K | ﹤0.01% | 5257 |
|
|
2017
Q2 | – | Sell |
-8,779
| Closed | -$104K | – | 6046 |
|
|
2017
Q1 | $104K | Hold |
8,779
| – | – | ﹤0.01% | 4945 |
|
|
2016
Q4 | $115K | Buy |
8,779
+3,994
| +83% | +$52.3K | ﹤0.01% | 4865 |
|
|
2016
Q3 | $69K | Hold |
4,785
| – | – | ﹤0.01% | 4911 |
|
|
2016
Q2 | $57K | Sell |
4,785
-945
| -16% | -$11.3K | ﹤0.01% | 4937 |
|
|
2016
Q1 | $107K | Buy |
5,730
+887
| +18% | +$16.6K | ﹤0.01% | 4619 |
|
|
2015
Q4 | $104K | Sell |
4,843
-182
| -4% | -$3.91K | ﹤0.01% | 4710 |
|
|
2015
Q3 | $85K | Buy |
5,025
+4,532
| +919% | +$76.7K | ﹤0.01% | 4815 |
|
|
2015
Q2 | $18K | Buy |
493
+450
| +1,047% | +$16.4K | ﹤0.01% | 5411 |
|
|
2015
Q1 | $1K | Buy |
+43
| New | +$1K | ﹤0.01% | 5830 |
|